VS

Venkata Subba Raju Vegiraju

Director Director DIN 02230297
DIN 02230297 First appointment Jan 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2007
Shareholding value •••• Premium profile

About Venkata Subba Raju Vegiraju

Data last updated:

Venkata Subba Raju Vegiraju was a Director at Shree Jaya Laboratories Private Limited (2013–2015) and Director at Asb Laboratories Private Limited (2007–2008). The companies operate in Pharma.

DIN 02230297
Primary Designation Director
Industry Pharma
First Appointment 29 Jan 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20132005₹187 Cr (FY 2025)Active
Asb Laboratories Private Limited U24119TG2006PTC051653
Director29 Jan 20072006Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shree Jaya Laboratories Private Limited
Asb Laboratories Private Limited
Premium access

Shareholding and investment profile for Venkata Subba Raju Vegiraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Subba Raju Vegiraju

Venkata Subba Raju Vegiraju was first appointed on 29 Jan 2007 as Director at Asb Laboratories Private Limited. The most recent appointment on record is 31 Mar 2013 at Shree Jaya Laboratories Private Limited.

Venkata Subba Raju Vegiraju held 2 earlier board appointments: Shree Jaya Laboratories Private Limited (Director, 31 Mar 2013 to 07 Jan 2015); Asb Laboratories Private Limited (Director, 29 Jan 2007 to 17 Apr 2008).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available